Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMA approves OncoGenex's development plan for OGX-011

Feb. 26, 2010

Genta initiates once-weekly treatment schedule for tesetaxel

Feb. 26, 2010

Roche reports on phase III trial of Avastin in ovarian cancer

Feb. 26, 2010

Sigma-Tau reports identification of novel HSP90 inhibitors

Feb. 26, 2010

HSP90 inhibitor STA-9090 targets oncogenic functions of Wilms tumor protein in AML cells

Feb. 25, 2010

Enzon treats first pediatric cancer patient in phase I PEG-SN38 trial

Feb. 25, 2010

Phase III NOV-002 trial in NSCLC fails to meet primary endpoint

Feb. 25, 2010

Hutchison MediPharma presents novel epidermal growth factor receptor inhibitors

Feb. 25, 2010

Novel focal adhesion kinase inhibitors discovered at AstraZeneca

Feb. 25, 2010

European CHMP issues two positive opinions for GSK's Tyverb and Votrient in cancer

Feb. 24, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...